Takeda Pharmaceuticals Expands Los Angeles, California, Operations
06/17/2024
The investment will enable the company to meet the growing demand for plasma-derived therapies for people with rare, chronic and genetic diseases, such as immunodeficiencies and bleeding disorders.
“We are pleased to make this investment at our LA site, demonstrating our commitment to our manufacturing footprint in the U.S.,” said Thomas Wozniewski, global manufacturing & supply officer at Takeda. “The U.S. is playing a critical role in our global manufacturing network and contributing to our supply chain resilience globally. The new facility will provide additional plasma fractionation capacity of up to 2 million litres per year enabling us to produce more plasma-derived therapies for patients in need.”
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company and the third largest pharmaceutical company in Asia. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines.
“Global demand for plasma-derived therapies has increased over the past 20 years, and continues to grow due to increasing diagnosis rates, improvements in standard of care and broader access to treatment across more countries." noted Giles Platford, president, plasma derived therapies at Takeda. “The Los Angeles expansion will support us in serving more patients with life-transforming therapies and help them live a better life.”
Project Announcements
Oldcastle APG Plans Lancaster, South Carolina, Operations
05/10/2025
Vantive Plans Deerfield, Illinois, Headquarters Operations
05/10/2025
SkyWest Airlines Plans Shreveport, Louisiana, Maintenance Operations
05/10/2025
Hissho Sushi Plans Rock Hill, South Carolina, Headquarters-Distribution Operations
05/09/2025
Nelson Brothers Expands Walker County, Alabama, Operations
05/04/2025
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024